Latest stories on NP
Neptune Insurance Holdings Inc. 2026 Q3 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Neptune Insurance price target lowered to $35 from $36 at Morgan Stanley
The Fly38 · neutralanalyst
Neptune Insurance price target raised to $33 from $31 at Mizuho
The Fly63 · neutralanalyst
Neptune Insurance: 3 Key Takeaways for Long-Term Investors
The Motley Fool63 · neutralgeneral
Mizuho raises Neptune Insurance stock price target to $33 on guidance
Investing.com Analyst Ratings64 · neutralanalyst
Neptune Insurance price target raised to $33 from $32 at Keefe Bruyette
The Fly61 · neutralanalyst
Neptune projects about $238M of 2027 revenue with about 61% adjusted EBITDA margin as Atlas+ adoption expands
Seeking Alpha74 · bullishearnings
Neptune Insurance Holdings Inc. (NP) Q3 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Neptune (NP) Q3 2026 Earnings Call Transcript
The Motley Fool74 · bullishearnings
Neptune Insurance Holdings Names Melej CFO, Succeeding Steiner
MarketWatch50 · neutralgeneral
Neptune Insurance CFO Jim Steiner to step down after annual filing
Seeking Alpha48 · neutralgeneral
Neptune Insurance Reports Record Q3 Results and Growth
TipRanks72 · bullishearnings
Neptune Insurance reports Q3 EPS 17c, consensus 16c
The Fly56 · neutralearnings
Neptune Insurance Holdings Inc. Non-GAAP EPS of $0.17 beats by $0.01, revenue of $59.5M beats by $3.15M
Seeking Alpha63 · neutralearnings
Neptune Insurance Holdings Inc. Reports Third Quarter 2026 Results
StockTitan50 · neutralearnings
Neptune Insurance Holdings Inc. (NP) files 8-K
SEC 8-K50 · neutralgeneral
Piper Sandler reiterates Neptune Insurance stock rating ahead of earnings
Investing.com Analyst Ratings52 · neutralanalyst
Neptune Insurance price target lowered to $34 from $37 at Wells Fargo
The Fly34 · bearishanalyst
Neptune Insurance price target lowered to $32 from $33 at Keefe Bruyette
The Fly38 · neutralanalyst
Neptune Insurance Holdings to Announce Third Quarter 2026 Financial Results
StockTitan50 · neutralearnings
Neptune Insurance price target lowered to $31 from $32 at Mizuho
The Fly42 · neutralanalyst
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
GlobeNewswire63 · neutralproduct/pr
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
Business Insider63 · neutralproduct/pr
8-K/A - Neptune Insurance Holdings Inc. (NP) files 8-K
SEC 8-K50 · neutralgeneral
Neptune Makes Flood Insurance Ready for the AI Agent Era
StockTitan63 · neutralproduct/pr